These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 12705171)
1. Azelastine eye drops in the treatment of perennial allergic conjunctivitis. Nazarov O; Petzold U; Haase H; Nguyen DT; Ellers-Lenz B; Hermann R Arzneimittelforschung; 2003; 53(3):167-73. PubMed ID: 12705171 [TBL] [Abstract][Full Text] [Related]
2. Comparison of azelastine eye drops with levocabastine eye drops in the treatment of seasonal allergic conjunctivitis. Giede C; Metzenauer P; Petzold U; Ellers-Lenz B Curr Med Res Opin; 2000; 16(3):153-63. PubMed ID: 11191004 [TBL] [Abstract][Full Text] [Related]
3. Topical azelastine in perennial allergic conjunctivitis. Canonica GW; Ciprandi G; Petzold U; Kolb C; Ellers-Lenz B; Hermann R Curr Med Res Opin; 2003; 19(4):321-9. PubMed ID: 12841925 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the onset and duration of effect of azelastine eye drops (0.05%) versus placebo in patients with allergic conjunctivitis using an allergen challenge model. Friedlaender MH; Harris J; LaVallee N; Russell H; Shilstone J Ophthalmology; 2000 Dec; 107(12):2152-7. PubMed ID: 11097587 [TBL] [Abstract][Full Text] [Related]
6. Azelastine eye-drops in seasonal allergic conjunctivitis or rhinoconjunctivitis. A double-blind, randomized, placebo-controlled study. Giede-Tuch C; Westhoff M; Zarth A Allergy; 1998 Sep; 53(9):857-62. PubMed ID: 9788686 [TBL] [Abstract][Full Text] [Related]
7. Dose-dependent protection by azelastine eye drops against pollen-induced allergic conjunctivitis. A double-blind, placebo-controlled study. Horak F; Berger UE; Menapace R; Toth J; Stübner PU; Marks B Arzneimittelforschung; 1998 Apr; 48(4):379-84. PubMed ID: 9608880 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy and tolerability of topically administered azelastine, sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis and rhino-conjunctivitis. James IG; Campbell LM; Harrison JM; Fell PJ; Ellers-Lenz B; Petzold U Curr Med Res Opin; 2003; 19(4):313-20. PubMed ID: 12841924 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age. Wober W; Diez Crespo CD; Bähre M Arzneimittelforschung; 1997 Jul; 47(7):841-4. PubMed ID: 9272242 [TBL] [Abstract][Full Text] [Related]
10. Azelastine eye drops in the treatment of seasonal allergic conjunctivitis or rhinoconjunctivitis in young children. Sabbah A; Marzetto M Curr Med Res Opin; 1998; 14(3):161-70. PubMed ID: 9787982 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis. Corren J; Storms W; Bernstein J; Berger W; Nayak A; Sacks H; Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303 [TBL] [Abstract][Full Text] [Related]
12. Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children. Abelson MB; Torkildsen GL; Williams JI; Gow JA; Gomes PJ; McNamara TR; Clin Ther; 2009 Sep; 31(9):1908-21. PubMed ID: 19843481 [TBL] [Abstract][Full Text] [Related]
13. The effect of intranasal azelastine and beclomethasone on the symptoms and signs of nasal allergy in patients with perennial allergic rhinitis. Davies RJ; Lund VJ; Harten-Ash VJ Rhinology; 1993 Dec; 31(4):159-64. PubMed ID: 7908144 [TBL] [Abstract][Full Text] [Related]
14. A randomized double-blind placebo controlled study of azelastine nasal spray in children with perennial rhinitis. Herman D; Garay R; Le Gal M Int J Pediatr Otorhinolaryngol; 1997 Feb; 39(1):1-8. PubMed ID: 9051434 [TBL] [Abstract][Full Text] [Related]
15. Double-blind, randomised, placebo-controlled study of two concentrations of azelastine eye drops in seasonal allergic conjunctivitis or rhinoconjunctivitis. Lenhard G; Mivsek-Music E; Perrin-Fayolle M; Obtulowicz K; Secchi A Curr Med Res Opin; 1997; 14(1):21-8. PubMed ID: 9524790 [TBL] [Abstract][Full Text] [Related]
16. Treatment of severe seasonal rhinoconjunctivitis by a combination of azelastine nasal spray and eye drops: a double-blind, double-placebo study. Duarte C; Baëhre M; Gharakhanian S; Leynadier F; J Investig Allergol Clin Immunol; 2001; 11(1):34-40. PubMed ID: 11436969 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of azelastine nasal spray in patients with allergic rhinitis compared to placebo and budesonide. Dorow P; Aurich R; Petzold U Arzneimittelforschung; 1993 Aug; 43(8):909-12. PubMed ID: 8105785 [TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy and safety of azelastine and levocabastine nasal sprays in patients with seasonal allergic rhinitis. Falser N; Wober W; Rahlfs VW; Baehre M Arzneimittelforschung; 2001; 51(5):387-93. PubMed ID: 11413739 [TBL] [Abstract][Full Text] [Related]
19. Rapid anti-inflammatory action of azelastine eyedrops for ongoing allergic reactions. Ciprandi G; Cosentino C; Milanese M; Tosca MA Ann Allergy Asthma Immunol; 2003 Apr; 90(4):434-8. PubMed ID: 12722967 [TBL] [Abstract][Full Text] [Related]
20. Investigation of long-term efficacy and tolerability of azelastine nasal spray in the treatment of perennial allergic rhinitis. Gastpar H; Dorow P; Aurich R; Petzold U Arzneimittelforschung; 1993 Jul; 43(7):771-6. PubMed ID: 8103660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]